{"cik":1445499,"taxonomy":"us-gaap","tag":"OtherAssetsCurrent","label":"Other Assets, Current","description":"Amount of current assets classified as other.","entityName":"IMPEL PHARMACEUTICALS INC","units":{"USD":[{"end":"2021-12-31","val":105000,"accn":"0000950170-22-024997","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-14","frame":"CY2021Q4I"},{"end":"2022-09-30","val":772000,"accn":"0000950170-22-024997","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-14","frame":"CY2022Q3I"},{"end":"2022-12-31","val":649000,"accn":"0000950170-23-021513","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-12"},{"end":"2022-12-31","val":649000,"accn":"0000950170-23-043366","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-18"},{"end":"2022-12-31","val":649000,"accn":"0000950170-23-063759","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-14","frame":"CY2022Q4I"},{"end":"2023-03-31","val":680000,"accn":"0000950170-23-021513","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-12","frame":"CY2023Q1I"},{"end":"2023-06-30","val":418000,"accn":"0000950170-23-043366","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-18","frame":"CY2023Q2I"},{"end":"2023-09-30","val":621000,"accn":"0000950170-23-063759","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-14","frame":"CY2023Q3I"}]}}